KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Non-Current Debt (2016 - 2023)

Chemed (CHE) has 15 years of Non-Current Debt data on record, last reported at $16.2 million in Q1 2023.

  • For Q1 2023, Non-Current Debt fell 86.46% year-over-year to $16.2 million; the TTM value through Mar 2023 reached $16.2 million, down 86.46%, while the annual FY2022 figure was $92.5 million, 50.0% down from the prior year.
  • Non-Current Debt reached $16.2 million in Q1 2023 per CHE's latest filing, down from $92.5 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $185.0 million in Q4 2021 and bottomed at $16.2 million in Q1 2023.
  • Average Non-Current Debt over 5 years is $107.9 million, with a median of $100.0 million recorded in 2019.
  • Peak YoY movement for Non-Current Debt: surged 60.0% in 2020, then crashed 86.46% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $90.0 million in 2019, then surged by 77.78% to $160.0 million in 2020, then grew by 15.62% to $185.0 million in 2021, then tumbled by 50.0% to $92.5 million in 2022, then plummeted by 82.43% to $16.2 million in 2023.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $16.2 million in Q1 2023, $92.5 million in Q4 2022, and $95.8 million in Q3 2022.